SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | 0.0% | 2,990 | +15.1% | 0.00% | 0.0% |
| Q2 2022 | $5,000 | 0.0% | 2,597 | +18.3% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | 0.0% | 2,196 | +89.8% | 0.00% | 0.0% |
| Q4 2021 | $5,000 | +25.0% | 1,157 | +131.4% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | -50.0% | 500 | -37.3% | 0.00% | 0.0% |
| Q2 2021 | $8,000 | +14.3% | 797 | -1.1% | 0.00% | -66.7% |
| Q1 2021 | $7,000 | +75.0% | 806 | +35.9% | 0.00% | +50.0% |
| Q4 2020 | $4,000 | -42.9% | 593 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $7,000 | +75.0% | 593 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $4,000 | +300.0% | 593 | +97.7% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 300 | -40.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 500 | +66.7% | 0.00% | – |
| Q1 2019 | $1,000 | – | 300 | +50.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 200 | -33.3% | 0.00% | – |
| Q3 2018 | $1,000 | -75.0% | 300 | -40.0% | 0.00% | -100.0% |
| Q2 2018 | $4,000 | +300.0% | 500 | +150.0% | 0.00% | – |
| Q1 2018 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |